Terrance McGuire, Director at ACCELERON PHARMA INC (XLRN), sold 69,213 shares at $30.96 ($2.1M) on 2016-12-08, disclosed to the SEC on 2016-12-09.
Open-market sale of $2.1M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.96 | 643 | $20K | 0.9% |
| 2 | $30.96 | 34,285 | $1.1M | 49.5% |
| 3 | $30.96 | 34,285 | $1.1M | 49.5% |
| Total | $30.96 avg | 69,213 | $2.1M | 100% |
| Filing → |
| IVVD | SELL | 2024-12-26 | $215K | — | Filing → |
| IVVD | SELL | 2024-12-19 | $213K | — | Filing → |
| IVVD | SELL | 2024-12-16 | $103K | — | Filing → |